Email this article Cytoflavin efficiency in poststroke period of cerebral blood flow ischemic violation
- Authors: Scoromets A.A.1, Nikitina V.V.1, Golikov K.V.2, Borisov A.V.2, Brodskaya Z.L.3, Skvortsova T.Y.3, Rudas M.S.3, Evtyukhina A.N.4, Lytschev A.A.4
-
Affiliations:
- SPb SMU acad. I. P. Pavlov
- City Clinical Hosp. № 2
- RAS Human Brain Institute
- City Hosp. № 31
- Issue: Vol 3, No 2 (2003)
- Pages: 90-97
- Section: Clinical medicine
- Published: 06.06.2003
- URL: https://journals.eco-vector.com/MAJ/article/view/693218
- ID: 693218
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
Effictency estimation of cytoflavin parenteral therapy of 41 patients at the age of 24 to 55 years with con- sequenses of acute violation of cerebral blood circulation in vertebral-basilar or carotid basin of ishemia type for a period of time from 3 months to 1 years of disease development is held.
After the cytoflavin therapeutic course of treatment the patients well-being is subjectively considerably improved, their headaches are reduced, their memory and sleepness are normalized. Improvement of cerebral microcirculation is supposed to lead to optimization of metabolic processes in cerebral subcortical structures, which is in the basis of improvement of psychic processes activity.
The cytoflavin preparation is well held by the patients without having any side effects and complications. It is recomended to order not more then 10 cytoflavin injections dairy with not less than 50 min. Duration of 1 course of treanment.
About the authors
A. A. Scoromets
SPb SMU acad. I. P. Pavlov
Author for correspondence.
Email: shabanov@mail.rcom.ru
Academician of the Russian Academy of Medical Sciences, Department of Neurology and Neurosurgery
Russian Federation, St. PetersburgV. V. Nikitina
SPb SMU acad. I. P. Pavlov
Email: shabanov@mail.rcom.ru
Department of Neurology and Neurosurgery
Russian Federation, St. PetersburgK. V. Golikov
City Clinical Hosp. № 2
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
A. V. Borisov
City Clinical Hosp. № 2
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
Z. L. Brodskaya
RAS Human Brain Institute
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
T. Yu. Skvortsova
RAS Human Brain Institute
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
M. S. Rudas
RAS Human Brain Institute
Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg
A. N. Evtyukhina
City Hosp. № 31
Email: shabanov@mail.rcom.ru
лаборатория молекулярной генетики
Russian Federation, St. PetersburgA. A. Lytschev
City Hosp. № 31
Email: shabanov@mail.rcom.ru
лаборатория молекулярной генетики
Russian Federation, St. PetersburgReferences
- Исаков В. А., Сологуб Т. В., Коваленко А. Л., Романцов М. Г. Реамберин в терапии критических состояний: Руководство для врачей. СПб., 2001. 158 с.
- Михайленко А. А., Иванов Ю. С., Семин Г. Ф. Ультразвуковая допплерография магистральных артерий головы и мозга. СПб.: Медицина, 1994. 75 с.
- Моляка Ю. К, Петрук С. В., Кирьянов С. А. и др. Анализ ассоциаций полиморфизма в гене ангиотензинпревращающего фермента при ишемическом инсульте // Журн. неврологии и псих. им. Корсакова. 1998. Т. 98. № 6. С. 35-37.
- Скоромец А. А. Краткий справочник врача- невролога. СПб.: Сотис, 1999. 352 с.
- Martinez-Aviles Р., Barba R., Andujar С. et al. Cerebrovascular accident in young adults. A study of 52 cases// Rev. Neurol. 1996. Vol. 128. № 24. P. 443-447.
- Takami S., Imai Y., Katsuya T. et al. Gene polymorphism of renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study // Am. J. Hypertens. 2000. Vol. 13. № 2. P. 121-127.
- Yaffe K., Haan M., Tangen C., Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction // Neurol. 2000. Vol. 54. № 10. P. 1949-1954.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).